Celldex Therapeutics
CLDX
#4701
Rank
โ‚น175.92 B
Marketcap
โ‚น2,647
Share price
-0.51%
Change (1 day)
19.96%
Change (1 year)

Celldex Therapeutics (CLDX) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : โ‚น4.50 Billion

According to Celldex Therapeutics's latest financial reports the company's total liabilities are โ‚น4.50 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Celldex Therapeutics - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚น3.88 B28.15%
2023-12-31โ‚น3.03 B38.24%
2022-12-31โ‚น2.19 B17.15%
2021-12-31โ‚น1.87 B-3.23%
2020-12-31โ‚น1.93 B-6.05%
2019-12-31โ‚น2.06 B-7.14%
2018-12-31โ‚น2.21 B-56.13%
2017-12-31โ‚น5.06 B-36.85%
2016-12-31โ‚น8.01 B153.98%
2015-12-31โ‚น3.15 B36.94%
2014-12-31โ‚น2.30 B36.61%
2013-12-31โ‚น1.68 B3.48%
2012-12-31โ‚น1.62 B5.25%
2011-12-31โ‚น1.54 B-0.38%
2010-12-31โ‚น1.55 B-49.7%
2009-12-31โ‚น3.09 B24.45%
2008-12-31โ‚น2.48 B502.19%
2007-12-31โ‚น0.41 B-84.31%
2006-12-31โ‚น2.62 B275.14%
2005-12-31โ‚น0.70 B118.65%
2004-12-31โ‚น0.32 B107.8%
2003-12-31โ‚น0.15 B-17.35%
2002-12-31โ‚น0.18 B-52.96%
2001-12-31โ‚น0.39 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Seagen
SGEN
โ‚น97.43 B 2,064.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
โ‚น46.27 B 927.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น78.97 B 1,654.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น7.238 T 160,699.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น10.395 T 230,819.00%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น5.509 T 122,282.78%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
โ‚น23.64 M-99.47%๐Ÿ‡บ๐Ÿ‡ธ USA